Skip to content
HowShorted

Tyra Biosciences, Inc. short interest in 2025

In 2025, Tyra Biosciences, Inc.'s disclosed short interest ran from 5.48% of shares outstanding on 15 Jan 2025 to 10.85% on 31 Dec 2025, a change of +5.37 percentage points. The year's high was 11.37% on 15 Jul 2025 and its low 5.48% on 15 Jan 2025, averaging 9.06% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.19 days on 15 Oct 2025. Full history: Tyra Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tyra Biosciences, Inc. in 2025

2025 in figures

Start of year
5.48% (15 Jan 2025)
End of year
10.85% (31 Dec 2025)
Change
+5.37 pp
High
11.37% (15 Jul 2025)
Low
5.48% (15 Jan 2025)
Average
9.06%
Highest days to cover
33.19 (15 Oct 2025)
SEC filings marked
8

Every report in 2025

Tyra Biosciences, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20255.48%8.66
31 Jan 20255.57%13.97
14 Feb 20257.28%12.44
28 Feb 20258.06%20.26
14 Mar 20257.74%8.49
31 Mar 20257.06%16.9110-K filed, results (8-K)
15 Apr 20257.41%8.73
30 Apr 20258.20%18.42
15 May 20259.61%15.2510-Q filed, results (8-K)
30 May 20259.37%19.62
13 Jun 20259.91%11.28
30 Jun 202510.47%14.25
15 Jul 202511.37%18.84
31 Jul 202511.23%28.94
15 Aug 202510.78%32.8910-Q filed, results (8-K)
29 Aug 202511.11%23.28
15 Sep 202511.17%26.23
30 Sep 202511.10%33.07
15 Oct 202510.85%33.19
31 Oct 20258.82%16.51
14 Nov 20258.20%18.4110-Q filed, results (8-K)
28 Nov 20257.77%5.75
15 Dec 20257.94%9.09
31 Dec 202510.85%10.65

See also: Tyra Biosciences, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.